Related Experiment Videos

FDG positron emission tomographic imaging of pseudo-pseudo tumor

Madhusudhan P Reddy¹, Yusuf Menda, Joseph Floresca

¹Department of Radiology, Division of Nuclear Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242-1077, USA.

Clinical Nuclear Medicine

|June 5, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Feasibility of treating neuroendocrine prostate cancer with anti-SSTR radioligands: A systematic review of imaging and treatment studies.

Seminars in nuclear medicine·2026

Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

CD8 PET imaging with [89Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study.

Journal for immunotherapy of cancer·2026

131I-LNTH-1095 Radioligand Therapy plus Enzalutamide versus Enzalutamide Alone in Men with PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase II Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

A Phase 0 Imaging Trial of [203Pb]Pb-VMT-α-NET to Enable Dosimetry and Treatment Planning for Refractory or Relapsed Metastatic Neuroendocrine Tumors with [212Pb]Pb-VMT-α-NET.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Enhancing PRRT Outcome Prediction in Neuroendocrine Tumors: Aggregated Multi-Lesion PET Radiomics Incorporating Inter-Tumor Heterogeneity.

Cancers·2025

See all related articles